2024-05-07T19:58:24-04:00 2023-12-31 330990695 LGH CONSULTING INC 585 S STATE COLLEGE BLVD ANAHEIM CA 928064222 990 2023-01-01 593432665 FRONTIERS IN BIOSCIENCE FRON 9497158286 20 SUNSET COVE NEWPORT COAST CA 92657 SIAMAK TABIBZADEH MD CEO 9497158286 2024-04-30 true SIAMAK TABIBZADEH XXX-XX-XXXX false GEORGE HUKRIEDE P01881448 7148089170 2024-05-07 2023 2023-04-26 12:10:37Z SIAMAK TABIBZADEH MD 20 SUNSET COVE NEWPORT COAST CA 92657 382834 false X WWW.BIOSCIENCE.ORG X FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END. 3 0 2 87919 45112 9394 145199 0 24026 152090 -39029 91347 130196 252831 0 0 150463 148771 0 9474 121640 115873 272103 264644 -141907 -11813 9068473 9132862 175870 252072 8892603 8880790 X FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END. false false 227404 FOSTERING SCIENCE, RESEARCH AND TEACHING IN THE AREAS OF MEDICINE, BIOLOGY,CANCER AND AGING. 227404 true false false false false false false false false false true false false false true false false false false false false false false false false false false false false false false false false true false false false false false false false false false false false false false false 0 0 false 2 false true true false false false false false false false X 3 0 false false false false false false false true true false false false false false false false false false CA SIAMAK TABIBZADEH MD 9497158286 20 SUNSET COVE NEWPORT COAST CA 92657 X SIAMAK TABIBZADEH MD CEO X X 0 0 0 SHILA ROOFIM CFO X X 0 0 0 FOROUGH SOOFERIAN SEC X X 0 0 0 false false false 9394 9394 152090 151604 486 3428 3428 217698 130003 87695 87695 87695 MISC 900099 224 224 224 252831 155032 87919 486 88000 70400 8800 8800 50000 50000 10771 9423 674 674 1750 1750 45662 45662 1213 1213 PROPERTY TAXES 31189 31189 UTILITIES 13837 13837 LAB SUPPLIES 10051 10051 REPAIRS AND MAINTENANCE 4416 4416 7755 7716 39 264644 227404 27766 9474 219428 105269 3006672 3348302 6906239 1232409 5774036 5673830 68337 5461 9068473 9132862 154516 233187 21354 18885 175870 252072 X 8892603 8880790 8892603 8880790 9068473 9132862 X -11813 18532 X false false X 9394 9394 286789 147977 155032 589798 286789 147977 164426 599192 599192 8428 27615 486 36529 8428 27615 486 36529 17915 86919 104834 17915 295217 175592 251831 740555 0.80910 0.88960 0.05000 0.07000 X 3229805 3229805 3288605 850042 2438563 387829 382367 5462 5673830 TENANT DEPOSITS 16890 CREDIT CARD/ PAYROLL TAXES 1995 18885 DIRECTOR TO AID THE ORGAN TO ACQUIRED INVEST X 154000 233187 false true true 233187 FORM 990 - ORGANIZATION'S MISSION FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END. FORM 990 SEE ATTACHMENT NOVEMBER 20, 2022 PART IV, LINE 63, LOANS FROM OFFICERS, DIRECTOR AND EMPLOYEE ON NOVEMBER 20, 2002, FRONTIERS IN BIOSCIENCE, INC. PURCHASED FOR INVESTMENT PURPOSES ONLY RESIDENTIAL REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NEW YORK. IN CONNECTION WITH THE ORGANIZATION'S PURCHASE OF SAID REAL ESTATE, FRONTIERS IN BIOSCIENCE INC., INCURRED A MORTGAGE PAYABLE WITH THE PRESIDEN AND FOUNDER, SIAMAK TABIBZADEH, MD, IN THE AMOUNT OF 145,000 LENDER'S NAME: SIAMAK TABIBZADEH, MD ORIGINAL AMOUNT OF NOTE: 154,000 BALANCE DUE: 145,555 DATE OF NOTE: NOVEMBER 20, 2002 MATURITY DATE: OPEN, SEE BELOW REPAYMENT TERMS: PRINCIPAL AND ACCRUED INTEREST DUE UPON SALE OF PROPERTY INTEREST RETE: RATE OF 4.5% PER ANNUM, PRINCIPAL AND INTEREST DUE UPON SALE OF PROPERTY OR AT SUCH TIME AS THE BOARD OF DIRECTOR DETERMINES THAT THERE ARE SUFFICIENT OPERATING FUNDS TO RETIRE THE OBILIGATION SECURITY PRIOVIDED BY THE BORROWER: MORTGAGE NOTE SECURED BY REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NY 11507 PURPOSE OF THE LOAN: TO BE ABLE TO PURCHASE REAL ESTATE AT BELOW FAIR MARKET VALUE TO SEE IN NO LONGER THAN TWO OPERATING CYCLES IN ORDER TO OBTAIN SUFFICIENT FUNDING TO ENDOW A FULL TIME MEDICAL RESEARCHER AND EDITOR. INTERST CALCUATION ORIGINAL AMOUNT OF PRINCIPAL: 154,000 FROM TO INTEREST AMOUNT (RATE, 4.5%) - PRINCIPAL + INTEREST NOV 20, 2002 154,000 NOV 20, 2002 NOV 20, 2003 6,930 - 160,930 - 15,375 REMOVED PRINCIPAL & INTEREST LEAVING 145,555 NOV 20, 2003 NOV 20, 2004 6,549 - 152,104 NOV 20, 2004 NOV 20, 2005 6,844 - 158,948 NOV 20, 2005 NOV 20, 2006 7,152 - 166,100 NOV 20, 2006 NOV 20, 2007 7,474 - 173,574 NOV 20, 2007 NOV 20, 2008 7,810 - 181,384 NOV 20, 2008 NOV 20, 2009 8,162 - 189,546 NOV 20, 2009 NOV 20, 2010 8,529 - 198,075 NOV 20, 2010 NOV 20, 2011 8,913 - 206,988 NOV 20, 2011 NOV 20, 2012 9,314 - 216,302 NOV 20, 2012 NOV 20, 2013 9,733 - 226,035 NOV 20, 2013 NOV 20, 2014 10,171 - 236,206 NOV 20, 2014 NOV 20, 2015 10,629 - 257,942 NOV 20, 2015 NOV 20, 2016 11,107 - 246,835 NOV 20, 2016 NOV 20, 2017 11,607 - 269,549 PRINCIPAL PAID 269,549-145,555=123,994 NOV 20, 2017 NOV 20, 2018 5,579 - 129,573 NOV 20, 2018 NOV 20, 2019 5,830 - 135,403 NOV 20, 2019 NOV 20, 2020 6,093 - 141,496 NOV 20, 2020 NOV 20, 2021 6,367 - 147,863 NOV 20, 2021 NOV 20, 2022 6,653 - 154,516 TO CORRECT FUNDS FOR INVESTMENT 11/30/03 78,671- 233187 FORM 990, PAGE 6, PART VI, LINE 11B NO REVIEW WAS OR WILL BE CONDUCTED. FORM 990, PAGE 6, PART VI, LINE 19 NO DOCUMENTS AVAILABLE TO THE PUBLIC FORM 990, PART XI ADJUSTMENT TO BEGINNING OF VALUE OF INVESTMENTS -14160 FORM 990, PART XI, LINE 9 BOOK / TAX DEPRECIATION DIFFERENCE 18,532